Cargando…

Update on the development of Group A Streptococcus vaccines

Detalles Bibliográficos
Autores principales:	Ajay Castro, Sowmya, Dorfmueller, Helge C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502077/ https://www.ncbi.nlm.nih.gov/pubmed/37709900 http://dx.doi.org/10.1038/s41541-023-00730-x

Ejemplares similares

A brief review on Group A Streptococcus pathogenesis and vaccine development
por: Castro, Sowmya Ajay, et al.
Publicado: (2021)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Group B streptococcus vaccines: one step further
por: Berner, Reinhard
Publicado: (2021)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Rethinking vaccine hesitancy among minority groups
por: Khan, Mishal S, et al.
Publicado: (2021)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

COVID-19 vaccination advice via SMS-based video to improve vaccination uncertainty in at-risk groups
por: Bateman, James, et al.
Publicado: (2021)

Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560
por: Cossrow, Nicole, et al.
Publicado: (2022)

Assortative mixing among vaccination groups and biased estimation of reproduction numbers
por: Klaus, Colin, et al.
Publicado: (2022)

COVID-19 Surveillance of Healthcare Workers during the SARS-CoV-2 Vaccination Period: An Updated Protocol Suggestion
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2021)

General Streptococcus
Publicado: (1918)

Developing Zika vaccines: the lessons for disease X
por: Barrett, Alan D. T.
Publicado: (2018)

Age and frailty in COVID-19 vaccine development
por: Andrew, Melissa K, et al.
Publicado: (2021)

The starting line for COVID-19 vaccine development
por: Lee, Nelson, et al.
Publicado: (2020)

Developing COVID-19 vaccine policy in increments
por: Saag, Michael S
Publicado: (2021)

Group A, B, C, and G Streptococcus Lancefield antigen biosynthesis is initiated by a conserved α-d-GlcNAc-β-1,4-l-rhamnosyltransferase
por: Zorzoli, Azul, et al.
Publicado: (2019)

Vaccine development during global epidemics: the Zika experience
por: Castanha, Priscila M S, et al.
Publicado: (2020)

Inclusion of pregnant women in COVID-19 vaccine development
por: Heath, Paul T, et al.
Publicado: (2020)

Vaccine development lessons between HIV and COVID-19
por: Vasan, Sandhya, et al.
Publicado: (2021)

COVID pandemic: updates from Cuba
por: Salas, Daniel
Publicado: (2020)

Comment on “Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”
por: Kenyon, Chris
Publicado: (2019)

Cancer and COVID-19 vaccines: a complex global picture
por: Yusuf, Aasim, et al.
Publicado: (2021)

The cost and challenge of vaccine development for emerging and emergent infectious diseases
por: Maslow, Joel N
Publicado: (2018)

Schistosomiasis: Basic requirements for the development of a subunit vaccine, using genetic vectors
por: Ahmad, Gul
Publicado: (2022)

The use of systems biology and immunological big data to guide vaccine development
por: Blohmke, Christoph J., et al.
Publicado: (2015)

Implications of COVID-19 for patients with pre-existing digestive diseases: an update
por: Mao, Ren, et al.
Publicado: (2021)

Paediatric out-of-hospital cardiac arrest: Time to update registries?
por: Katzenschlager, Stephan, et al.
Publicado: (2023)

SARS-CoV-2 infection and COVID-19 and human reproduction – A changing perspective – A 2022 update
por: Delamuta, Luciana C., et al.
Publicado: (2023)

Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
por: Benavides-Zora, David, et al.
Publicado: (2023)

Comment on Propofol and survival: an updated meta-analysis of randomized clinical trials
por: Glass, Adam, et al.
Publicado: (2023)

Covid19 Outbreak in Victoria, Australia Update August 1, 2020
por: Boretti, Alberto
Publicado: (2020)

Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond
por: Oberemok, V. V., et al.
Publicado: (2022)

Main group carbonyl complexes
por: Fujimori, Shiori, et al.
Publicado: (2020)

Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes
por: Vogel, Joshua P, et al.
Publicado: (2022)

Vaccine safety in an era of novel vaccines: a proposed research agenda
por: Poland, Gregory A., et al.
Publicado: (2022)

Patients with gout: an under-recognised group at high risk of COVID-19
por: Dalbeth, Nicola, et al.
Publicado: (2021)

Group prenatal care: effectiveness and challenges to implementation
por: Andrade-Romo, Zafiro, et al.
Publicado: (2019)

Workplace contact patterns across occupational groups
por: Welsh, Claire E.
Publicado: (2022)

Vaccine transparency
por: Liverpool, Layal
Publicado: (2021)

What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil?
por: Sato, Ana Paula Sayuri
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ciacq507loscp6lnu0hl3mhtuu